Live Breaking News & Updates on Caba

Stay informed with the latest breaking news from Caba on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Caba and stay connected to the pulse of your community

Cabaletta Bio, Inc. (NASDAQ:CABA) Given Average Rating of "Buy" by Brokerages

Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) has received an average recommendation of “Buy” from the nine analysts that are covering the firm, MarketBeat.com reports. Nine investment analysts have rated the stock with a buy rating. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year […]

Wellington , New-zealand-general- , New-zealand , Blackstone-inc , Cantor-fitzgerald , Cabaletta-bio-inc , Cabaletta-bio-company-profile , Victory-capital-management-inc , Wells-fargo-company , Nasdaq , Wellington-management-group

Brokerages Set Cabaletta Bio, Inc. (NASDAQ:CABA) Target Price at $34.33

Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) has been assigned an average recommendation of “Buy” from the nine ratings firms that are presently covering the firm, Marketbeat reports. Nine equities research analysts have rated the stock with a buy rating. The average 1-year price target among brokerages that have updated their coverage on the […]

Wellington , New-zealand-general- , New-zealand , Switzerland , Swiss , Jennison-associates , Vanguard-group-inc , Wells-fargo-company , Nasdaq , Cantor-fitzgerald , Citigroup-inc

Cabaletta Bio, Inc. (NASDAQ:CABA) Receives Consensus Recommendation of "Buy" from Analysts

Shares of Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) have been given a consensus rating of “Buy” by the nine ratings firms that are currently covering the firm, MarketBeat reports. Nine investment analysts have rated the stock with a buy recommendation. The average 12-month target price among brokers that have issued a report on […]

Gwendolyn-binder , Nasdaq , Cantor-fitzgerald , Cabaletta-bio-inc , Macroview-investment-management , Ameritas-investment-partners-inc , Comerica-bank , Wells-fargo-company , Jefferies-financial-group , Barclays-plc , Cabaletta-bio , Get-free-report

Cabaletta Bio (NASDAQ:CABA) Rating Reiterated by Cantor Fitzgerald

Cantor Fitzgerald restated their overweight rating on shares of Cabaletta Bio (NASDAQ:CABA – Free Report) in a report published on Friday, Benzinga reports. They currently have a $50.00 price target on the stock. Several other brokerages also recently weighed in on CABA. William Blair restated an outperform rating and set a $38.00 price objective on […]

Switzerland , Swiss , William-blair , Gwendolyn-binder , Rafferty-asset-management , Swiss-national-bank , Cantor-fitzgerald , Citigroup-inc , Securities-exchange-commission , Wells-fargo-company , Morgan-stanley , Barclays-plc

Comparing Cabaletta Bio (NASDAQ:CABA) & Aptose Biosciences (NASDAQ:APTO)

Cabaletta Bio (NASDAQ:CABA – Get Free Report) and Aptose Biosciences (NASDAQ:APTO – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, valuation and institutional ownership. Analyst Recommendations This is a breakdown of […]

Pennsylvania , United-states , Canada , Philadelphia , University-of-pennsylvania , Aptose-biosciences , Aptose-bioscience , Tycho-therapeutics-inc , Cabaletta-bio-inc , Aptose-biosciences-inc , Crystalgenomics-inc , Lorus-therapeutics-inc

Jefferies Financial Group Initiates Coverage on Cabaletta Bio (NASDAQ:CABA)

Jefferies Financial Group assumed coverage on shares of Cabaletta Bio (NASDAQ:CABA – Free Report) in a research report report published on Monday morning, MarketBeat reports. The firm issued a buy rating and a $36.00 price target on the stock. A number of other research firms have also commented on CABA. William Blair reiterated an outperform […]

Stifel-nicolaus , Gwendolyn-binder , William-blair , Jefferies-financial-group , Securities-exchange-commission , Cantor-fitzgerald , Vanguard-group-inc , Acadian-asset-management , Morgan-stanley , York-mellon-corp , Dynamic-technology-lab-private-ltd , Cabaletta-bio-inc

Cabaletta Bio Gets Orphan Drug Designation for Potential Autoimmune Disease Treatment

By Ben Glickman Cabaletta Bio announced it had received orphan drug designation from regulators for its potential treatment for an inflammatory muscle...

Ben-glickman , Drug-administration , Article-normal , Biotechnology-services , Pharmaceuticals , Healthcare-life-sciences , Biopharmaceuticals , Biological-therapy , Healthcare-provision , Autoimmune-diseases , Political-general-news , Health

Cabaletta Bio (NASDAQ:CABA) Stock Price Down 5.6%

Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report)’s share price fell 5.6% during trading on Tuesday . The stock traded as low as $21.22 and last traded at $21.86. 67,430 shares traded hands during mid-day trading, a decline of 91% from the average session volume of 757,777 shares. The stock had previously closed at $23.15. […]

China , Stifel-nicolaus , Gwendolyn-binder , William-blair , Morgan-stanley , China-universal-asset-management-co , Denali-advisors , Nasdaq , Sg-americas-securities , Cantor-fitzgerald , Cabaletta-bio-inc , Vanguard-group-inc

Cabaletta Bio (NASDAQ:CABA) Stock Price Up 7.1%

Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report)’s stock price rose 7.1% on Thursday . The stock traded as high as $22.08 and last traded at $21.95. Approximately 216,444 shares were traded during trading, a decline of 73% from the average daily volume of 788,854 shares. The stock had previously closed at $20.50. Analyst Ratings […]

William-blair , Stifel-nicolaus , Gwendolyn-binder , Ameritas-investment-partners-inc , Comerica-bank , Securities-exchange-commission , Cabaletta-bio-company-profile , Cabaletta-bio-inc , Barclays-plc , Nasdaq , Cantor-fitzgerald , Dynamic-technology-lab-private-ltd

Cabaletta Bio (NASDAQ:CABA) Trading Up 7.1%

Cabaletta Bio, Inc. (NASDAQ:CABA – Get Free Report) shares shot up 7.1% during trading on Thursday . The stock traded as high as $22.08 and last traded at $21.95. 216,444 shares were traded during trading, a decline of 73% from the average session volume of 788,854 shares. The stock had previously closed at $20.50. Analyst […]

Stifel-nicolaus , Gwendolyn-binder , William-blair , Dynamic-technology-lab-private-ltd , Cabaletta-bio-inc , York-mellon-corp , Securities-exchange-commission , Vanguard-group-inc , Cantor-fitzgerald , Morgan-stanley , Cabaletta-bio-company-profile , Acadian-asset-management